Navigation Links
University Hospital of Bordeaux Officially Opens New Electrophysiology Lab

New Lab Features Installation of Stereotaxis Magnetic Navigation System at

Prestigious Research Center

ST. LOUIS, Dec. 4 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today the official opening of the Stereotaxis Magnetic Navigation System at the new electrophysiology (EP) lab at the University Hospital of Bordeaux, France. The lab is headed by Professors Michel Haissaguerre and Pierre Jais, whose discovery of the ectopic foci that trigger atrial fibrillation (AF) in 1998 paved the way for new ablation techniques for more effectively treating this disease which affects millions of people worldwide.

The new EP lab was unveiled today in a ceremony at which Alain Heriaud, General Director of CHU of Bordeaux, Bevil Hogg, CEO of Stereotaxis and Alain Juppe, Mayor of Bordeaux and president of the board of directors of CHU of Bordeaux, presided.

"We are very enthusiastic about the present and future applications for the Stereotaxis system, which represents an engineering tour de force," said Professor Haissaguerre. "Today the Stereotaxis system allows stable and precise catheter positioning potentially better than manual manipulation. Our initial experience on atrial fibrillation using the magnetic irrigated catheter is very promising, suggesting notably the potential for a higher safety margin in comparison with conventional manipulation while maintaining at least equivalent efficacy."

"Our next goal is to achieve complete automation of the many different techniques necessary for catheter ablation of cardiac arrhythmias and particularly atrial fibrillation. We hope our partnership with Stereotaxis will be mutually beneficial in achieving our goals of further understanding and treating the most complex rhythm disturbances leading to better patient care," Professor Haissaguerre concluded.

"The installation of the Stereotaxis Niobe(R) system in Bordeaux represents a significant milestone for us, and we are particularly honored that the system has been installed at the University Hospital of Bordeaux, one of the leading research institutions in the world for electrophysiology," said Bevil Hogg, CEO of Stereotaxis. "We are also proud to note that Bordeaux has installed the Stereotaxis system with an Odyssey(TM) Network Solution. Odyssey is a powerful fully-networked user interface that consolidates the multiple information sources and systems of a traditional electrophysiology lab into one large screen with single mouse control, and has the potential to contribute significantly to procedure room simplification and work-flow productivity, and through its private network, to promote the dissemination of best practices worldwide."

"The recent launch of our partnered irrigated catheter has now expanded to multiple sites in Europe, and we are very pleased with the initial results," continued Mr. Hogg. "A significant number of cases using the irrigated catheter have now been performed, and we are gratified to note the high success rate in terms of outcomes and patient safety."

"Professor Haissaguerre and his team are pioneers in the discovery of new approaches to the treatment of AF and we look forward to using our collaboration with the Bordeaux team to advance scientific understanding and treatment of cardiac arrhythmias. We are honored to pay tribute to this esteemed team by participating in the opening of their new EP lab," concluded Mr. Hogg.

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. Stereotaxis has research agreements with certain leading institutions worldwide, including Bordeaux, France. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada. Note that use of cardiac ablation catheters for treatment of atrial fibrillation is considered investigational in the United States.

About Forward Looking Statements

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance for the Company's products in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that we will recognize revenue related to our purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of our control. In addition, these orders and commitments may be revised, modified or canceled, either by their express terms, as a result of negotiations, or by project changes or delays.

SOURCE Stereotaxis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. University of Iowa professor identifies new eating disorder
2. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. Tulane University to receive $14M for international HIV/AIDS program
5. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
6. Boston University School of Medicine researcher recipient of Memory Ride Grant
7. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
8. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
9. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
10. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
11. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
Post Your Comments:
(Date:11/30/2015)... ... 2015 , ... Third Molar SEO , one of ... launched a sleek, mobile-ready and user-centric redesigned website. , Vivek Srivastava, founder and ... the benefits that its SEO services provide to dentists and why Third Molar ...
(Date:11/30/2015)... ... 01, 2015 , ... The National Association of Professional Women (NAPW) ... the Year Circle. She is recognized with this prestigious distinction for leadership in estate ... boasting more than 850,000 members and over 200 operating Local Chapters. , “I’m pleased ...
(Date:11/30/2015)... ... November 30, 2015 , ... Until now, the St. Louis Fetal ... MOMS (Management of Myelomeningocele Study) trial. One of these exclusion criteria was a BMI ... of 18.5 to 24.9 is considered normal, 25 - 29.9 is overweight and above ...
(Date:11/30/2015)... ... November 30, 2015 , ... An extensive ... is specialized and only includes chiropractic clinics in the US. , The team ... alternative health practitioner when back pain sets in. When people are experiencing back ...
(Date:11/30/2015)... ... November 30, 2015 , ... On Saturday, October 24th, 2015, at the ... annual fundraising event, a 5K walk known as “Making Strides Against Breast Cancer”. Patients ... which is also located in Battle Creek, joined in for this campaign that sought ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015  QT Vascular Ltd., together with its ... its subsidiaries, TriReme Medical LLC and Quattro Vascular Pte. ... the design, assembly and distribution of advanced therapeutic solutions ... pleased to announce that a three-judge panel of ... for the Federal Circuit ("Federal Circuit") has unanimously granted ...
(Date:11/30/2015)... 30, 2015   Royal Philips  (NYSE: ... of Radiology Solutions, a fully integrated, consultative approach ... customized, data-driven practice management approaches that combine imaging ... practices improve care delivery and reduce costs. Making ... of North America Annual Meeting (RSNA) in ...
(Date:11/30/2015)... Nautilus Medical Inc. today announced worldwide availability of MatrixRay, ... The release of MatrixRay to the entire medical healthcare ... America) in Chicago - the ... --> --> MatrixRay is the first ... worldwide via a peer-to-peer exchange network of physicians and ...
Breaking Medicine Technology: